Market View 03rd August, 2026

View on market: Volatility persists, eagerly searching for growth:

Asian markets began the week on a weak note, with South Korea and Japan leading the decline, while Australia also traded lower. Investors remained cautious despite a fall in crude oil prices after the US President decided against another military action on Iran. Lower oil prices offered some relief, but global uncertainty continued to keep market sentiment under pressure. US markets remained strong as technology stocks continued Sto support the rally. Buying interest in major technology companies and chipmakers lifted overall sentiment, while the previous trading session also ended with broad-based gains, reflecting optimism over the sector’s growth outlook. In India, benchmark indices ended higher in the last trading session on Friday after opening on a muted note. Buying in auto and pharmaceutical stocks helped the market recover and close with gains. Domestic sentiment remained positive, although investors are expected to track global market trends and upcoming domestic triggers.

Key Quarterly Results

Chemcon Speciality, INOX India, SBI Funds Management, Texmaco Rail & Engineering, CAMS, GESHIP, KCP, Kaya, Artemis Medicare, Ather Energy Ltd, Bharat Gears Ltd, Borosil Scientific, Butterfly Gandhimathi Appliances, Dhanuka Agritech, DLF Ltd, Escorts Kubota, Ethos LtdGlaxoSmithKline Pharmaceuticals Ltd, IREDA, Jindal Stainless , Kalpataru Ltd, Kansai Nerolac Paints, KEI Industries, Munjal Showa, Nazara Technologies Ltd, NOCIL Ltd, Torrent Power Ltd, UPL Ltd

Economic Calendar:

• USD: S&P Global and ISM Manufacturing PMI Data on 03^rd August 2026.
• IND: HSBC Manufacturing PMI Data on 03^rd August 2026.
• USD: Import and Export Data on 04^th August 2026.
• IND: Monetary Policy on 05^th August 2026.

BROKERAGE RADAR:

CITI ON DIVIS LAB Target 11700 Earlier Target ₹9450 Recommendation Equal-weight, Validation Drives Strong Beat, Commercial Volumes Can Transform Earnings Trajectory, Margins may remain elevated, Strong commentary on peptides, contrast media and generics, Hike earnings estimate by 8-15%; retain Divis as top India Pharma pick.

MORGAN STANLEY ON COAL INDIA: Target ₹420 Recommendation Equal-weight, Calculations suggest that thermal power demand rose ~12% YoY in July-26 helped by a favorable base, Adjusted for favorable base, Coal India volumes have lagged thermal power demand, Inventory levels are now comfortable and we may see some restocking over the next few months, Will monitor the thermal power demand trajectory over the next few months.

KOTAK SECURITIES ON GAIL: Target ₹215 Earlier Target *175 Recommendation Accumulate, Q1FY27: Record profit amid worst disruptions, Disruption boosted profitability across marketing, LPG/LHC and petchem, with minimal impact on transmission volumes, Conviction on GAIL being key winner of disruption stronger.

KOTAK SECURITIES ON ZEE ENTERTAINMENT: Target ₹130 Earlier Target ₹90 Recommendation Add, Setting the stage for value unlocking, Zee to issue warrants to raise promoter holding to 23.8% from 3.99%, Core business headwinds are unlikely to recede, Music business value unlock could be a near to medium term trigger.

International Markets:

U.S & Europe:

*As per 03^rd August.

Asian markets:

Stocks strong on Chart:

Commodities & Currency:

FRIENDS & FRIENDS:

View on market: Volatility persists, eagerly searching for growth

News Updates:

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited (Elite Wealth Limited is wholly owned subsidiary of InCred Capital Financial Services Limited) does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

1. All of the views expressed in the report accurately reflect his or her personal views about any and all of

the subject securities or issuers; and

2. No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale. Legal

Entities Disclosures

Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. 1. 1. Reports
      2. EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
      3. EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
      4. EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
3. EWL  or its associates have not received any compensation from the subject company in the past twelve months;
4. EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
5. EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
6. EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
7. EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research
8. In respect of Public Appearances
9. EWL or its associates have not received any compensation from the subject company in the past twelve months;
10. The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL